Neuronetics’ MDD Therapy System Snags Shonnin Approval

Neuronetics received Japan’s Shonnin approval for a transcranial magnetic stimulation non-drug treatment option for major depressive disorder treatment.

The NeuroStar Advanced Therapy system uses MRI magnetic field pulses to non-invasively stimulate underactive areas of the brain delivering electroconvulsive therapy. It also provides real-time feedback to physicians.

The system has received approval for commercial distribution in the U.S. and it is CE marked.